| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000041980 |
| Receipt No. | R000047915 |
| Scientific Title | Examination of the effects of vegetable oil intake on immunity and mental and physical QOL (motivation, cognition, etc.) for healthy adult men and women who are worried about mental and physical deterioration due to aging |
| Date of disclosure of the study information | 2021/12/27 |
| Last modified on | 2021/03/31 (Ver. 4) |
| Basic information | ||
| Public title | Examination of the effects of vegetable oil intake on immunity and mental and physical QOL | |
| Acronym | Examination of the effects of vegetable oil intake on immunity and mental and physical QOL | |
| Scientific Title | Examination of the effects of vegetable oil intake on immunity and mental and physical QOL (motivation, cognition, etc.) for healthy adult men and women who are worried about mental and physical deterioration due to aging | |
| Scientific Title:Acronym | Examination of the effects of vegetable oil intake on immunity and mental and physical QOL (motivation, cognition, etc.) for healthy adult men and women who are worried about mental and physical deterioration due to aging | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adult | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the effect of vegetable oil intake for 8 consecutive weeks on immunity and mental and physical QOL using placebo as a control |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | PASAT and Stroop before and after 8 weeks |
| Key secondary outcomes | s-IgA and SF-36 before and after 8 weeks |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | NO |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Ingest vegetable oil for 8 consecutive weeks | |
| Interventions/Control_2 | Ingest placebo for 8 consecutive weeks | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Healthy males and females from 40 years of age
(2) Subjects who are aware of the deterioration of memory due to aging (3) Subjects with inferior scores of primary outcome (4) Subjects with inferior score on the questionnaire |
|||
| Key exclusion criteria | (1) Subjects who regularly use health foods, etc. that contain many ingredients that may affect research results
(2) Subjects who have symptoms that affect the performance of the test (3) Subjects having a disease requiring treatment or a history of serious diseases for which medication was required (4) Subjects who have been diagnosed as menopausal symptoms (5) Subjects who have depressive symptoms, or who have been diagnosed as depressive disorder (6) Subjects who take medications that may affect research results (7) Subjects who have diseases requiring regular administration, or who have severe diseases (8) Subjects who sometimes have irregular lifestyles during the study (9) Smokers or subjects who started smoking cessation within 12 months (10) Subjects who have performed the same tests as the primary endpoint of this study within 12 months (11) Subjects who have done blood transfusion or blood donation within 3 months (12) Subjects who have participated in other clinical studies within 1 month, or who are planning to participate in other clinical studies during this study (13) Subjects who are, or are planning to be pregnant or breastfeeding during study (14) Subjects who are judged as unsuitable by doctor for laboratory value, anthropometric measurements, or physical examination value (15) Subjects who are at risk of developing allergies related to research (16) Subjects who are judged as unsuitable due to lifestyle questionnaire (17) Subjects who are judged as unsuitable by doctor for other reasons |
|||
| Target sample size | 40 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Medical Corporation Kensho-kai, Fukushima Healthcare Center | ||||||
| Division name | Internal Medicine, Department of Neurosurgery | ||||||
| Zip code | 553-0004 | ||||||
| Address | 2-12-16 Tamagawa, Fukushima-ku, Osaka-shi, Osaka | ||||||
| TEL | 06-6882-1130 | ||||||
| s.kondo@drc-web.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | TTC Co., Ltd. | ||||||
| Division name | Clinical Research Planning Department | ||||||
| Zip code | 150-0021 | ||||||
| Address | Seibu Shinkin Bank Ebisu Bldg.,1-20-2, Ebisunishi, Shibuya-ku, Tokyo | ||||||
| TEL | 03-5459-5329 | ||||||
| Homepage URL | |||||||
| k.isobe@ttc-tokyo.co.jp | |||||||
| Sponsor | |
| Institute | TTC Co., Ltd |
| Institute | |
| Department | |
| Funding Source | |
| Organization | non-disclosure |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Medical Station Clinic Research Ethics Committee |
| Address | 3-12-8, Takaban, Meguroku, Tokyo |
| Tel | 03-6452-2712 |
| t.saito@ttc-smo.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047915 |